Abdolmaleky H.M. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 2006, 15(21):3132-3145.
Aleman A., Formisano E., et al. The functional neuroanatomy of metrical stress evaluation of perceived and imagined spoken words. Cereb. Cortex 2005, 15(2):221-228.
Aleman A., Swart M., et al. Brain imaging, genetics and emotion. Biol. Psychol. 2008, 79(1):58-69.
Bach M. Predictive value of alexithymia: a prospective study in somatizing patients. Psychother. Psychosom. 1995, 64(1):43-48.
Berthoz S., Ouhayoun B., et al. Comparison of the psychometric properties of two self-report questionnaires measuring alexithymia: confirmatory factor analysis of the 20-item Toronto Alexithymia Scale and the Bermond-Vorst Alexithymia Questionnaire. Eur. Rev. Appl. Psychol. 2000, 50(4):359-368.
Berthoz S., Perdereau F., et al. Observer- and self-rated alexithymia in eating disorder patients: levels and correspondence among three measures. J. Psychosom. Res. 2007, 62(3):341-347.
Bertolino A., Rubino V., et al. Prefrontal-hippocampal coupling during memory processing is modulated by COMT Val158Met genotype. Biol. Psychiatry 2006, 60(11):1250-1258.
Bishop S.J., Cohen J.D., et al. COMT genotype influences prefrontal response to emotional distraction. Cogn. Affect. Behav. Neurosci. 2006, 6(1):62-70.
Chen J.S., Lipska B.K., et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 2004, 75(5):807-821.
Cohen, H., Neumann L., et al. (2009). The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia. Clin. Exp. Rheumatol. 27 (5 Suppl 56), S51-S56.
Davidson, R.J., Putnam, K.M., et al. (2000). Dysfunction in the neural circuitry of emotion regulation-a possible prelude to violence. Science 289 (5479), 591-594.
Dimaggio G., Vanheule S., et al. Impaired self-reflection in psychiatric disorders among adults: a proposal for the existence of a network of semi independent functions. Conscious. Cogn. 2009, 18(3):653-664.
Domschke K., Freitag C.M., et al. Association of the functional Val158Met catechol-O-methyl-transferase polymorphism with panic disorder in women. Int. J. Neuropsychopharmacol. 2004, 7(02):183-188.
Drabant E.M., Hariri A.R., et al. Catechol O-methyltransferase val(158)met genotype and neural mechanisms related to affective arousal and regulation. Arch. Gen. Psychiatry 2006, 63(12):1396-1406.
Egan M.F., Goldberg T.E., et al. Effect of COMT Val(108/158) Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl Acad. Sci. USA 2001, 98(12):6917-6922.
Eley T.C., Tahir E., et al. Association analysis of MAOA and COMT with neuroticism assessed by peers. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 120B(1):90-96.
Enoch M.A., Xu K., et al. Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr. Genet. 2003, 13(1):33-41.
Finan, P.H.P., Zautra, A.J.A., et al. (2010). Genetic influences on the dynamics of pain and affect in fibromyalgia. Health Psychol. 29 (2), 134-142. Erratum in: Health Psychol. 29 (3), 245.
Goldberg T.E., Egan M.F., et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch. Gen. Psychiatry 2003, 60(9):889-896.
Ham B.J., Lee M.S., et al. Association between the catechol O-methyltransferase Val108/158Met polymorphism and alexithymia. Neuropsychobiology 2005, 52(3):151-154.
Heinz A., Smolka M.N. The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Rev. Neurosci. 2006, 17(3):359-367.
Honkalampi K., Hintikka J., et al. Depression is strongly associated with alexithymia in the general population. J. Psychosom. Res. 2000, 48(1):99-104.
Huber A., Suman A.L., et al. Alexithymia in fibromyalgia syndrome: associations with ongoing pain, experimental pain sensitivity and illness behavior. J. Psychosom. Res. 2009, 66(5):425-433.
Kempton M.J., Haldane M., et al. The effects of gender and COMT Val158Met polymorphism on fearful facial affect recognition: a fMRI study. Int. J. Neuropsychopharmacol. 2009, 12(3):371-381.
Lachman H.M., Papolos D.F., et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6(3):243-250.
Lane R.D., Sechrest L., et al. Impaired verbal and nonverbal emotion recognition in alexithymia. Psychosom. Med. 1996, 58(3):203-210.
Lane R.D., Ahern G.L., et al. Is alexithymia the emotional equivalent of blindsight?. Biol. Psychiatry 1997, 42(9):834-844.
Lee K.H., Siegle G.J. Common and distinct brain networks underlying explicit emotional evaluation: a meta-analytic study. Soc. Cogn. Affect. Neurosci. 2009, 10.1093/scan/nsp001.
Lelli-Chiesa G., Kempton M.J., Jogia J., Tatarelli R., Girardi P., Powell J., Collier D.A., Frangou S. The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives. Psychol. Med. 2010, 1-10.
Lopez-Leon S., Janssens A.C.J.W., et al. Meta-analyses of genetic studies on major depressive disorder. Mol. Psychiatry 2008, 13(8):772-785.
Luminet O., Vermeulen N., et al. Alexithymia and levels of processing: evidence for an overall deficit in remembering emotion words. J. Res. Pers. 2006, 40(5):713-733.
Maddock R.J. The retrosplenial cortex and emotion: new insights from functional neuroimaging of the human brain. Trends Neurosci. 1999, 22(7):310-316.
Maddock R.J., Garrett A.S., et al. Posterior cingulate cortex activation by emotional words: fMRI evidence from a valence decision task. Hum. Brain Mapp. 2003, 18(1):30-41.
Mannisto P.T., Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 1999, 51(4):593-628.
Mantani T., Okamoto Y., et al. Reduced activation of posterior cingulate cortex during imagery in subjects with high degrees of alexithymia: a functional magnetic resonance imaging study. Biol. Psychiatry 2005, 57(9):982-990.
Mattila A.K. Alexithymia and somatization in general population. Psychosom. Med. 2008, 70(6):716-722.
McIntosh A.M., Baig B.J., et al. Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis. Biol. Psychiatry 2007, 61(10):1127-1134.
Mier, D., P. Kirsch, et al., 2010. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol. Psychiatry 15 (9), 918-927.
Montag C., Hartmann P., et al. COMT genetic variation affects fear processing: psychophysiological evidence. Behav. Neurosci. 2008, 122(4):901-909.
Mynett-Johnson L.A., Murphy V.E., et al. Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr. Genet. 1998, 8(4):221-225.
Nemiah J.C., Sifneos P.E. Psychosomatic illness - problem in communication. Psychother. Psychosom. 1970, 18(1-6):154-160.
Northoff G., Heinzel A., et al. Self-referential processing in our brain - a meta-analysis of imaging studies on the self. Neuroimage 2006, 31(1):440-457.
Norusius (2002). Statistical Package for the Social Sciences (SPSS).
Okochi T. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr. Res. 2009, 110(1-3):140-148.
Papolos D.F., Veit S., et al. Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol. Psychiatry 1998, 3(4):346-349.
Paradiso S., Johnson D.L., et al. Cerebral blood flow changes associated with attribution of emotional valence to pleasant, unpleasant, and neutral visual stimuli in a PET study of normal subjects. Am. J. Psychiatry 1999, 156(10):1618-1629.
Posner J., Russell J.A., et al. The neurophysiological bases of emotion: an fMRI study of the affective circumplex using emotion-denoting words. Hum. Brain Mapp. 2009, 30(3):883-895.
Raichle M.E., MacLeod A.M., et al. A default mode of brain function. Proc. Natl Acad. Sci. USA 2001, 98(2):676-682.
Sifneos P.E. The prevalence of 'alexithymic' characteristics in psychosomatic patients. Psychother. Psychosom. 1973, 22(2):255-262.
Slifstein M., Kolachana B., et al. COMT genotype predicts cortical-limbic D1 receptor availability measured with [C-11]NNC112 and PET. Mol. Psychiatry 2008, 13(8):821-827.
Smolka M.N., Schumann G., et al. Catechol-O-methyltransferase val(158)met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J. Neurosci. 2005, 25(4):836-842.
Suslow T. Alexithymia and automatic affective processing. Eur. J. Pers. 1998, 12(6):433-443.
Svoboda E., McKinnon M.C., et al. The functional neuroanatomy of autobiographical memory: a meta-analysis. Neuropsychologia 2006, 44(12):2189-2208.
Swart M., Kortekaas R., et al. Dealing with feelings: characterization of trait alexithymia on emotion regulation strategies and cognitive-emotional processing. PLoS ONE 2009, 4(6):e5751.
Taylor G.J., Bagby R.M., et al. Disorders of Affect Regulation Alexithymia in Medical and Psychiatric Illness 1997, Cambridge University Press, Cambridge.
van der Meer L., Costafreda S., et al. Self-reflection and the brain: a theoretical review and meta-analysis of neuroimaging studies with implications for schizophrenia. Neurosci. Biobehav. Rev. 2010, 34(6):935-946.
van 't Wout M., Aleman A., et al. No words for feelings: alexithymia in schizophrenia patients and first-degree relatives. Compr. Psychiatry 2007, 48(1):27-33.
Vermeulen N., Luminet O., et al. Alexithymia and the automatic processing of affective information: evidence from the affective priming paradigm. Cogn. Emotion 2006, 20(1):64-91.
Vermeulen N., Luminet O., et al. Categorical perception of anger is disrupted in alexithymia: evidence from a visual ERP study. Cogn. Emotion 2008, 22(6):1052-1067.
Vorst H.C.M., Bermond B. Validity and reliability of the Bermond-Vorst Alexithymia Questionnaire. Pers. Individ. Differ. 2001, 30:413-434.
Watson D., Clark L.A., et al. Development and validation of brief measures of positive and negative affect: the PANAS scales. J. Pers. Soc. Psychol. 1988, 54(6):1063-1070.
Waugh C.E., Dearing K.F., et al. Association between the catechol-O-methyltransferase Val158Met polymorphism and self-perceived social acceptance in adolescent girls. J. Child Adolesc. Psychopharmacol. 2009, 19(4):395-401.
Weiss E.M., Stadelmann E., et al. Differential effect of catechol-O-methyltransferase Val(158) Met genotype on emotional recognition abilities in healthy men and women. J. Int. Neuropsychol. Soc. 2007, 13(5):881-887.
Williams, L. M., J. M. Gatt, et al., 2010. COMT Val(108/158)Met polymorphism effects on emotional brain function and negativity bias. Neuroimage 53 (3), 918-925.
Woo J.M., Yoon K.S., et al. The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. J. Psychiatr. Res. 2007, 38(4):365-370.
Zech E., Luminet O., et al. Alexithymia and its measurement: confirmatory factor analyses of the 20-item Toronto Alexithymia Scale and the Bermond-Vorst Alexithymia Questionnaire. Eur. J. Pers. 1999, 13(6):511-532.
Zubieta J.K., Heitzeg M.M., et al. COMT val(158)met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003, 299(5610):1240-1243.
